[HTML][HTML] Manufacturing of human extracellular vesicle-based therapeutics for clinical use
M Gimona, K Pachler, S Laner-Plamberger… - International journal of …, 2017 - mdpi.com
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
[PDF][PDF] Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
E Rohde - Int. J. Mol. Sci, 2017 - academia.edu
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
M Gimona, K Pachler… - International …, 2017 - search.ebscohost.com
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
M Gimona, K Pachler… - International …, 2017 - search.proquest.com
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
[HTML][HTML] Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
M Gimona, K Pachler, S Laner-Plamberger… - … Journal of Molecular …, 2017 - ncbi.nlm.nih.gov
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
[引用][C] Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
M Gimona, K Pachler, S Laner-Plamberger… - INTERNATIONAL …, 2017 - pure.pmu.ac.at
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use. — PMU
Forschungsportal Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt …
Forschungsportal Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt …
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
M Gimona, K Pachler… - International …, 2017 - pubmed.ncbi.nlm.nih.gov
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
[PDF][PDF] Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
E Rohde - Int. J. Mol. Sci, 2017 - pdfs.semanticscholar.org
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
[PDF][PDF] Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use
E Rohde - Int. J. Mol. Sci, 2017 - researchgate.net
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …
Manufacturing of Human Extracellular Vesicle-Based Therapeutics for Clinical Use.
M Gimona, K Pachler, S Laner-Plamberger… - … Journal of Molecular …, 2017 - europepmc.org
Extracellular vesicles (EVs) derived from stem and progenitor cells may have therapeutic
effects comparable to their parental cells and are considered promising agents for the …
effects comparable to their parental cells and are considered promising agents for the …